BSX vs. IHI

Last updated Jun 3, 2026

BSX (Boston Scientific Corporation) is a stock, while IHI (iShares U.S. Medical Devices ETF) is Health & Biotech Equities fund tracking the Dow Jones U.S. Select Medical Equipment Index. Over the past 10 years, BSX returned 7.66%/yr vs 8.52%/yr for IHI. A 0.67 correlation means they provide meaningful diversification when combined.

Performance

BSX vs. IHI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Boston Scientific Corporation (BSX) and iShares U.S. Medical Devices ETF (IHI). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, BSX achieves a -49.99% return, which is significantly lower than IHI's -22.40% return. Over the past 10 years, BSX has underperformed IHI with an annualized return of 7.66%, while IHI has yielded a comparatively higher 8.52% annualized return.

BSX

• 1D: -0.63%
• 1M: -15.61%
• YTD: -49.99%
• 6M: -51.85%
• 1Y: -54.23%
• 3Y*: -2.74%
• 5Y*: 2.89%
• 10Y*: 7.66%

IHI

• 1D: -1.33%
• 1M: -4.57%
• YTD: -22.40%
• 6M: -23.58%
• 1Y: -21.48%
• 3Y*: -3.29%
• 5Y*: -2.46%
• 10Y*: 8.52%

*Multi-year figures are annualized to reflect compound growth (CAGR)

BSX vs. IHI - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
BSX Boston Scientific Corporation	-49.99%	6.75%	54.51%	24.94%	8.92%	18.16%	-20.50%	27.96%	42.56%	14.61%
IHI iShares U.S. Medical Devices ETF	-22.40%	6.88%	8.62%	3.24%	-19.80%	21.03%	24.17%	32.75%	15.45%	30.81%

Correlation

The correlation between BSX and IHI is 0.55, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.55
Correlation (3Y) Calculated over the trailing 3-year period	0.61
Correlation (5Y) Calculated over the trailing 5-year period	0.66
Correlation (10Y) Calculated over the trailing 10-year period	0.70
Correlation (All Time) Calculated using the full available price history since May 8, 2006	0.67

The correlation between BSX and IHI shifts across timeframes, from 0.55 (1 year) to 0.70 (10 years), reflecting how their relationship changes across market environments.

Return for Risk

BSX vs. IHI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BSX

BSX Risk / Return Rank: 1
BSX Sharpe Ratio Rank: 0
BSX Sortino Ratio Rank: 1
BSX Omega Ratio Rank: 1
BSX Calmar Ratio Rank: 2
BSX Martin Ratio Rank: 0

IHI

IHI Risk / Return Rank: 1
IHI Sharpe Ratio Rank: 0
IHI Sortino Ratio Rank: 1
IHI Omega Ratio Rank: 1
IHI Calmar Ratio Rank: 2
IHI Martin Ratio Rank: 0

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BSX vs. IHI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Boston Scientific Corporation (BSX) and iShares U.S. Medical Devices ETF (IHI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	BSX	IHI	Difference
Sharpe ratio Return per unit of total volatility	-1.57	-1.29	-0.28
Sortino ratio Return per unit of downside risk	-2.40	-1.81	-0.59
Omega ratio Gain probability vs. loss probability	0.65	0.80	-0.15
Calmar ratio Return relative to maximum drawdown	-0.98	-0.84	-0.14
Martin ratio Return relative to average drawdown	-2.25	-2.17	-0.08
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

BSX vs. IHI - Sharpe Ratio Comparison

The current BSX Sharpe Ratio is -1.57, which is comparable to the IHI Sharpe Ratio of -1.29. The chart below compares the historical Sharpe Ratios of BSX and IHI, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	BSX	IHI	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-1.57	-1.29	-0.28
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.11	-0.13	+0.24
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.28	0.43	-0.15
Sharpe Ratio (All Time) Calculated using the full available price history	0.19	0.46	-0.27

Drawdowns

BSX vs. IHI - Drawdown Comparison

The maximum BSX drawdown since its inception was -89.15%, which is greater than IHI's maximum drawdown of -49.65%. Use the drawdown chart below to compare losses from any high point for BSX and IHI.

Drawdown Indicators

	BSX	IHI	Difference
Max Drawdown Largest peak-to-trough decline	-89.15%	-49.65%	-39.50%
Max Drawdown (1Y) Largest decline over 1 year	-55.91%	-26.11%	-29.80%
Max Drawdown (3Y) Largest decline over 3 years	-55.91%	-26.64%	-29.27%
Max Drawdown (5Y) Largest decline over 5 years	-55.91%	-33.12%	-22.79%
Max Drawdown (10Y) Largest decline over 10 years	-55.91%	-33.25%	-22.66%
Current Drawdown Current decline from peak	-55.91%	-26.73%	-29.18%
Average Drawdown Average peak-to-trough decline	-38.75%	-8.31%	-30.44%
Ulcer Index Depth and duration of drawdowns from previous peaks	24.31%	10.07%	+14.24%

Volatility

BSX vs. IHI - Volatility Comparison

Boston Scientific Corporation (BSX) has a higher volatility of 16.24% compared to iShares U.S. Medical Devices ETF (IHI) at 6.41%. This indicates that BSX's price experiences larger fluctuations and is considered to be riskier than IHI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BSX	IHI	Difference
Volatility (1M) Calculated over the trailing 1-month period	16.24%	6.41%	+9.83%
Volatility (6M) Calculated over the trailing 6-month period	32.81%	12.73%	+20.08%
Volatility (1Y) Calculated over the trailing 1-year period	34.64%	16.71%	+17.93%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	25.66%	18.95%	+6.71%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	27.29%	19.78%	+7.51%

Dividends

BSX vs. IHI - Dividend Comparison

BSX has not paid dividends to shareholders, while IHI's dividend yield for the trailing twelve months is around 0.46%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
BSX Boston Scientific Corporation	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
IHI iShares U.S. Medical Devices ETF	0.46%	0.34%	0.46%	0.53%	0.45%	0.25%	0.25%	0.33%	0.26%	0.37%	0.55%	1.28%

Frequently Asked Questions

Can I hold both BSX and IHI in my portfolio?

BSX and IHI have a correlation of 0.55, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, BSX or IHI?

BSX has higher volatility (16.24%) compared to IHI (6.41%). In terms of maximum drawdown, BSX dropped -89.15% vs IHI's -49.65%.

Which has better risk-adjusted returns?

IHI currently has the higher Sharpe Ratio (-1.29 vs -1.57), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.